Ultimately, anyone at risk of developing circulatory disorders will benefit from better technology for measuring cell deformability and critical shear stress. Quick and easy measurements at the point of care will provide earlier detection of the circulatory diseases including diabetic kidney disease and diabetic retinopathy , allowing patients to be treated on time and to have healthy life.
top of page
Search
Recent Posts
See AllCSS is the minimum shear stress needed to disaggregate RBC aggregation, and appears to be an excellent index to represent RBC...
1540
RheoScan received approval from Korea Food & Drug Administration(KFDA) though GMP tests as a First class medical device in Dec., 2005....
370
bottom of page
Comentarios